
Opinion|Videos|June 11, 2024
Navigating T1D Risk Screening: Identifying Ideal Candidates, Understanding Autoantibodies, and Determining Timing for Rescreening
Following a couple of audience polling questions, Andrea Stallings, PA and her UCSD colleagues, comment on identifying suitable candidates for T1D screening, understanding autoantibodies involved in this condition, and determining when to rescreen those at risk for disease progression.
Advertisement
Episodes in this series

Advertisement
Related to this article

Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Advertisement
Advertisement
Trending on Patient Care Online
1
When Night Sweats Signal Something Other Than Menopause
2
Abbott's Amulet 360 Linked to Low Stroke Risk at 1 Year in Late-Breaking Research
3
4 FDA Decisions for Primary Care to Know from October 2026
4
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
5





